Tone mix
Week by week 52 weeks
Share of Erasca, Inc. Common Stock's 402 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Mar 30, 2026 · tone -55Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't-121
- Week of Sep 15, 2025 · tone -100Erasca (NASDAQ:ERAS) Stock Rating Lowered by Wall Street Zen-114
- Week of Aug 24, 2026 · tone +100Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma+109
- Week of Aug 17, 2026 · tone +86Erasca (NASDAQ:ERAS) Price Target Raised to $22.00+97
- Week of Sep 22, 2025 · tone +100Erasca, Inc. (ERAS) Stock Analysis: Exploring A Potential 173% Upside In The Biotech Sector+75
- Week of Nov 10, 2025 · tone 0Erasca Reports Third Quarter 2025 Business Updates and Financial Results-75
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Erasca, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 0 | No headlines |
| Last 90 sessions | 243 | -10 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, September 15, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletErasca, Inc. $ERAS Shares Sold by Tidal Investments LLCNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Erasca, Inc. $ERAS Shares Sold by Tidal Investments LLC | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, September 8, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- finance.yahoo.com · 2 outletsFDA Fast Track Puts Erasca's (ERAS) Pancreatic Bet Center StagePositive
- www.dailypolitical.com · 1 outletErasca, Inc. $ERAS Shares Acquired by Wellington Management Group LLPNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FDA Fast Track Puts Erasca's (ERAS) Pancreatic Bet Center Stage | finance.yahoo.com | 2 | Positive |
| Erasca, Inc. $ERAS Shares Acquired by Wellington Management Group LLP | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, August 31, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletThe Manufacturers Life Insurance Company Buys New Stake in Erasca, Inc. $ERASNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| The Manufacturers Life Insurance Company Buys New Stake in Erasca, Inc. $ERAS | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, August 24, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletErasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic AdenocarcinomaPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Friday, August 21, 2026
1 headline, average tone +73: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletErasca, Inc. (NASDAQ:ERAS) Receives $21.91 Average PT from AnalystsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Erasca, Inc. (NASDAQ:ERAS) Receives $21.91 Average PT from Analysts | www.themarketsdaily.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Erasca, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.